Update in cystic fibrosis 2012.
作者信息
Goss Christopher H, Ratjen Felix
机构信息
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
出版信息
Am J Respir Crit Care Med. 2013 May 1;187(9):915-9. doi: 10.1164/rccm.201301-0184UP.
Abstract
摘要
相似文献
1
Update in cystic fibrosis 2012.
Am J Respir Crit Care Med. 2013 May 1;187(9):915-9. doi: 10.1164/rccm.201301-0184UP.
2
Hypertonic saline for cystic fibrosis: worth its salt?
Expert Rev Respir Med. 2014 Jun;8(3):267-9. doi: 10.1586/17476348.2014.896203. Epub 2014 Mar 26.
3
Inhaled hypertonic saline as a therapy for cystic fibrosis.
Curr Opin Pulm Med. 2006 Nov;12(6):445-52. doi: 10.1097/01.mcp.0000245714.89632.b2.
4
Hypertonic saline in cystic fibrosis.
Pediatr Pulmonol. 1996 Feb;21(2):73-4. doi: 10.1002/(SICI)1099-0496(199602)21:2<73::AID-PPUL1>3.0.CO;2-Q.
5
Mechanisms and applications of hypertonic saline.
J R Soc Med. 2011 Jul;104 Suppl 1(Suppl 1):S2-5. doi: 10.1258/jrsm.2011.s11101.
6
Question 2: should hypertonic saline be used in patients with cystic fibrosis who respond unsatisfactorily to recombinant deoxyribonuclease?
Arch Dis Child. 2010 Jul;95(7):562-4. doi: 10.1136/adc.2008.141226.
7
What did we learn from the North American Cystic Fibrosis Conference?
J R Soc Med. 2008 Jul;101 Suppl 1(Suppl 1):S6-9. doi: 10.1258/jrsm.2008.s18003.
8
Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: a prospective, randomized, double-blind, controlled study.
Ther Adv Respir Dis. 2012 Dec;6(6):315-22. doi: 10.1177/1753465812458984. Epub 2012 Sep 11.
9
Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
Am J Respir Crit Care Med. 1996 May;153(5):1503-9. doi: 10.1164/ajrccm.153.5.8630593.
10
Timing of hypertonic saline inhalation for cystic fibrosis.
Cochrane Database Syst Rev. 2012 Feb 15(2):CD008816. doi: 10.1002/14651858.CD008816.pub2.
引用本文的文献
1
Not Quite the Bully in the Schoolyard: Can Survive and Coexist with in the Cystic Fibrosis Lung.
Am J Respir Crit Care Med. 2021 Feb 1;203(3):279-281. doi: 10.1164/rccm.202008-3077ED.
2
CNS imaging studies in cystic fibrosis patients presenting with sudden neurological events.
BMJ Open Respir Res. 2019 Aug 9;6(1):e000456. doi: 10.1136/bmjresp-2019-000456. eCollection 2019.
3
Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis.
United European Gastroenterol J. 2017 Aug;5(5):609-624. doi: 10.1177/2050640616670565. Epub 2016 Sep 21.
4
Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence.
Ther Adv Respir Dis. 2017 May;11(5):193-209. doi: 10.1177/1753465817691239. Epub 2017 Feb 17.
5
Analysis and Characterization of Staphylococcus aureus Small Colony Variants Isolated From Cystic Fibrosis Patients in Austria.
Curr Microbiol. 2016 May;72(5):606-11. doi: 10.1007/s00284-016-0994-z. Epub 2016 Jan 28.
6
Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study.
Eur J Health Econ. 2017 Jan;18(1):73-82. doi: 10.1007/s10198-015-0759-9. Epub 2016 Jan 7.
7
Normal and Cystic Fibrosis Human Bronchial Epithelial Cells Infected with Pseudomonas aeruginosa Exhibit Distinct Gene Activation Patterns.
PLoS One. 2015 Oct 20;10(10):e0140979. doi: 10.1371/journal.pone.0140979. eCollection 2015.
8
Evidence for a Cystic Fibrosis Enteropathy.
PLoS One. 2015 Oct 20;10(10):e0138062. doi: 10.1371/journal.pone.0138062. eCollection 2015.
9
Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function.
World J Crit Care Med. 2015 Aug 4;4(3):179-91. doi: 10.5492/wjccm.v4.i3.179.
10
The Evolution of Cystic Fibrosis Care.
Chest. 2015 Aug;148(2):533-542. doi: 10.1378/chest.14-1997.
本文引用的文献
1
Socioeconomic barriers to lung transplantation: balancing access and equity.
Am J Respir Crit Care Med. 2012 Nov 15;186(10):937-9. doi: 10.1164/rccm.201210-1776ED.
2
Induced sputum biomarkers for monitoring cystic fibrosis lung disease.
Am J Respir Crit Care Med. 2012 Nov 1;186(9):812-4. doi: 10.1164/rccm.201209-1731ED.
3
Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status.
Am J Respir Crit Care Med. 2012 Nov 15;186(10):1008-13. doi: 10.1164/rccm.201205-0949OC. Epub 2012 Sep 13.
4
Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
Am J Respir Crit Care Med. 2012 Nov 1;186(9):846-56. doi: 10.1164/rccm.201206-1056OC. Epub 2012 Sep 6.
5
Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein.
Nat Biotechnol. 2012 Sep;30(9):876-82. doi: 10.1038/nbt.2328.
6
The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis.
Am J Respir Crit Care Med. 2012 Nov 15;186(10):999-1007. doi: 10.1164/rccm.201203-0478OC. Epub 2012 Aug 16.
7
Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.
Am J Respir Crit Care Med. 2012 Nov 1;186(9):857-65. doi: 10.1164/rccm.201203-0507OC. Epub 2012 Aug 16.
8
Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota.
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13769-74. doi: 10.1073/pnas.1107435109. Epub 2012 Aug 7.
9
Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity.
Am J Respir Cell Mol Biol. 2012 Dec;47(6):738-45. doi: 10.1165/rcmb.2012-0088OC. Epub 2012 Aug 3.
10
β-adrenergic sweat secretion as a diagnostic test for cystic fibrosis.
Am J Respir Crit Care Med. 2012 Oct 15;186(8):732-9. doi: 10.1164/rccm.201205-0922OC. Epub 2012 Aug 2.
Zotero 插件